Literature DB >> 8153871

Complement resistance in microbes.

M C Moffitt1, M M Frank.   

Abstract

Mesh：

Substances：

Year:  1994        PMID： 8153871     DOI： 10.1007/bf01837364

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN： 0344-4325


× No keyword cloud information.
  89 in total

1.  Bacterial capsules and interactions with complement and phagocytes.

Authors:  I S Roberts; F K Saunders; G J Boulnois
Journal:  Biochem Soc Trans       Date:  1989-06       Impact factor: 5.407

2.  Sialic acid of group B Neisseria meningitidis regulates alternative complement pathway activation.

Authors:  G A Jarvis; N A Vedros
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

3.  The immune-adherence phenomenon; an immunologically specific reaction between microorganisms and erythrocytes leading to enhanced phagocytosis.

Authors:  R A NELSON
Journal:  Science       Date:  1953-12-18       Impact factor: 47.728

4.  Protein A from Staphylococcus aureus. IX. Complement-fixing activity of protein A-IgG complexes.

Authors:  J Sjöquist; G Stålenheim
Journal:  J Immunol       Date:  1969-09       Impact factor: 5.422

5.  Antiphagocytic activity of streptococcal M protein: selective binding of complement control protein factor H.

Authors:  R D Horstmann; H J Sievertsen; J Knobloch; V A Fischetti
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

6.  Capsular antibodies induce type-specific phagocytosis of capsulated Staphylococcus aureus by human polymorphonuclear leukocytes.

Authors:  W W Karakawa; A Sutton; R Schneerson; A Karpas; W F Vann
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441

7.  Quantitative relationship between capsular content and killing of K1-encapsulated Escherichia coli.

Authors:  C Vermeulen; A Cross; W R Byrne; W Zollinger
Journal:  Infect Immun       Date:  1988-10       Impact factor: 3.441

8.  Role of Escherichia coli K capsular antigens during complement activation, C3 fixation, and opsonization.

Authors:  W C Van Dijk; H A Verbrugh; M E van der Tol; R Peters; J Verhoef
Journal:  Infect Immun       Date:  1979-08       Impact factor: 3.441

9.  Effect of Pseudomonas aeruginosa elastase and alkaline protease on serum complement and isolated components C1q and C3.

Authors:  Y Q Hong; B Ghebrehiwet
Journal:  Clin Immunol Immunopathol       Date:  1992-02

10.  Plasmid-determined resistance to serum bactericidal activity: a major outer membrane protein, the traT gene product, is responsible for plasmid-specified serum resistance in Escherichia coli.

Authors:  A Moll; P A Manning; K N Timmis
Journal:  Infect Immun       Date:  1980-05       Impact factor: 3.441
View more
  11 in total

1.  BrkA protein of Bordetella pertussis inhibits the classical pathway of complement after C1 deposition.

Authors:  M G Barnes; A A Weiss
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

2.  Killing of dsrA mutants of Haemophilus ducreyi by normal human serum occurs via the classical complement pathway and is initiated by immunoglobulin M binding.

Authors:  Malikah Abdullah; Igor Nepluev; Galyna Afonina; Sanjay Ram; Peter Rice; William Cade; Christopher Elkins
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

3.  Aptamer–biotin–streptavidin–C1q complexes can trigger the classical complement pathway to kill cancer cells.

Authors:  John Gordon Bruno
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-02       Impact factor: 2.416

4.  Characterization of BrkA expression in Bordetella bronchiseptica.

Authors:  A A Rambow; R C Fernandez; A A Weiss
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

5.  Functional characterization of exopolyphosphatase/guanosine pentaphosphate phosphohydrolase (PPX/GPPA) of Campylobacter jejuni.

Authors:  Anandkumar Malde; Dharanesh Gangaiah; Kshipra Chandrashekhar; Ruby Pina-Mimbela; Jordi B Torrelles; Gireesh Rajashekara
Journal:  Virulence       Date:  2014-02-25       Impact factor: 5.882

6.  Campylobacter capsule and lipooligosaccharide confer resistance to serum and cationic antimicrobials.

Authors:  Thormika Keo; Jennifer Collins; Pratima Kunwar; Martin J Blaser; Nicole M Iovine
Journal:  Virulence       Date:  2011-01-01       Impact factor: 5.882

7.  Polysaccharide capsule and sialic acid-mediated regulation promote biofilm-like intracellular bacterial communities during cystitis.

Authors:  Gregory G Anderson; Carlos C Goller; Sheryl Justice; Scott J Hultgren; Patrick C Seed
Journal:  Infect Immun       Date:  2010-01-19       Impact factor: 3.441

Review 8.  Complement and autoimmunity.

Authors:  Eleonora Ballanti; Carlo Perricone; Elisabetta Greco; Marta Ballanti; Gioia Di Muzio; Maria Sole Chimenti; Roberto Perricone
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

Review 9.  Pseudomonas aeruginosa lipopolysaccharide: a major virulence factor, initiator of inflammation and target for effective immunity.

Authors:  Gerald B Pier
Journal:  Int J Med Microbiol       Date:  2007-04-27       Impact factor: 3.473

10.  Characterization of human bactericidal antibodies to Bordetella pertussis.

Authors:  A A Weiss; P S Mobberley; R C Fernandez; C M Mink
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.